Henry Schein Stock Price and Value Analysis

Should you buy Henry Schein stock? (NasdaqGS:HSIC). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
  • This company has amazingly consistent growth!
  • This stock looks overpriced.
  • This company is less known than others.
  • This company is making money at a modest rate.
  • This company pays no dividend.

Inside the HSIC Numbers

HSIC Price
(Henry Schein stock price per share)
$82.11
[?]
HSIC Fair Price
(based on intrinsic value)
$50.28
[?]
HSIC Safety Price (based on a variable margin of safety) $30.17
[?]
PE Ratio versus Sector 43% higher than other Healthcare stocks
[?]
PE Ratio versus Industry 36% higher than other Unknown stocks
[?]
Cash Yield 5.92%
[?]
Free Cash Flow Jitter 9%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 4,357,964 shares shorted. With 134,565,758 shares available for purchase and an average trading volume over the past 10 trading days of 903,410, it would take at least 4.824 days for all of the short holders to cover their shorts.

Is Henry Schein Stock on Sale?

We believe that Henry Schein may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Henry Schein looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy HSIC Stock?

Does Henry Schein have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.